Early Esophageal Cancer And Pre Cancer Eliminated With Non Surgical Treatment Combination
BARRX Medical, Inc., a global technology leader in treating Barrett’s esophagus, announced the publication of two related European trials which report a 100% eradication rate for early esophageal cancer and pre-cancerous dysplasia using endoscopic resection followed by ablation therapy with the HALO ablation system.
More: continued here